ArticleThe Journal of clinical investigation2026

Estrogen receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancer.

José Ángel Palomeque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.